Similar articles for PMID: 30503643

Year	Number of Results
2006	2
2007	1
2008	3
2009	5
2010	2
2011	5
2012	3
2013	6
2014	6
2015	6
2016	6
2017	6
2018	5
2019	4
2020	1
2022	4
2023	1
2024	0

1

Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia.

Kang KH, Kim SH, Choi SY, Yoo HL, Lee MY, Song HY, Kee KM, Suh JH, Yang SY, Jang EJ, Lee SE, Kim DW. Kang KH, et al. Leuk Res. 2019 Jan;76:87-93. doi: 10.1016/j.leukres.2018.10.019. Epub 2018 Nov 27. Leuk Res. 2019. PMID: 30503643

2

Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemia.

Baer C, Kern W, Koch S, Nadarajah N, Schindela S, Meggendorfer M, Haferlach C, Haferlach T. Baer C, et al. Haematologica. 2016 Jul;101(7):830-8. doi: 10.3324/haematol.2016.145888. Epub 2016 Apr 21. Haematologica. 2016. PMID: 27102501 Free PMC article.

3

Analysis of ABL kinase domain mutations conferring resistance to tyrosine kinase inhibitors in chronic myeloid leukemia cases from India.

Bagadi S, Saikia T, Pany A, Das B. Bagadi S, et al. Clin Lab. 2011;57(7-8):619-23. Clin Lab. 2011. PMID: 21888027

4

Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia.

Mat Yusoff Y, Abu Seman Z, Othman N, Kamaluddin NR, Esa E, Zulkiply NA, Abdullah J, Zakaria Z. Mat Yusoff Y, et al. Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3317-3320. doi: 10.31557/APJCP.2018.19.12.3317. Asian Pac J Cancer Prev. 2018. PMID: 30583336 Free PMC article.

5

Analysis of Bcr-Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P-loop and T315I mutation is disease phase dependent.

Kim SH, Kim D, Kim DW, Goh HG, Jang SE, Lee J, Kim WS, Kweon IY, Park SH. Kim SH, et al. Hematol Oncol. 2009 Dec;27(4):190-7. doi: 10.1002/hon.894. Hematol Oncol. 2009. PMID: 19274615

6

Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance.

Patkar N, Ghodke K, Joshi S, Chaudhary S, Mascerhenas R, Dusseja S, Mahadik S, Gaware S, Tembhare P, Gujral S, Kabre S, Kadam-Amare P, Jain H, Dangi U, Bagal B, Khattry N, Sengar M, Arora B, Narula G, Banavali S, Menon H, Subramanian PG. Patkar N, et al. Leuk Lymphoma. 2016 Nov;57(11):2653-60. doi: 10.3109/10428194.2016.1157868. Epub 2016 Mar 21. Leuk Lymphoma. 2016. PMID: 26999421

7

HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.

Yun SM, Jung KH, Kim SJ, Fang Z, Son MK, Yan HH, Lee H, Kim J, Shin S, Hong S, Hong SS. Yun SM, et al. Cancer Lett. 2014 Jun 28;348(1-2):50-60. doi: 10.1016/j.canlet.2014.03.012. Epub 2014 Mar 18. Cancer Lett. 2014. PMID: 24657654

8

BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naïve and -exposed Southeast Asian chronic myeloid leukemia patients.

Wongboonma W, Thongnoppakhun W, Auewarakul CU. Wongboonma W, et al. Exp Mol Pathol. 2012 Apr;92(2):259-65. doi: 10.1016/j.yexmp.2012.01.007. Epub 2012 Jan 31. Exp Mol Pathol. 2012. PMID: 22314255

9

New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Mascarenhas CC, Cunha AF, Miranda EC, Zulli R, Silveira RA, Costa FF, Pagnano KB, De Souza CA. Mascarenhas CC, et al. Leuk Lymphoma. 2009 Jul;50(7):1148-54. doi: 10.1080/10428190902930496. Leuk Lymphoma. 2009. PMID: 19557636

10

Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.

Soverini S, De Benedittis C, Polakova KM, Linhartova J, Castagnetti F, Gugliotta G, Papayannidis C, Mancini M, Klamova H, Salvucci M, Crugnola M, Iurlo A, Albano F, Russo D, Rosti G, Cavo M, Baccarani M, Martinelli G. Soverini S, et al. Oncotarget. 2016 Apr 19;7(16):21982-90. doi: 10.18632/oncotarget.8010. Oncotarget. 2016. PMID: 26980736 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year